Vanguard Group Inc Insmed Inc Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Insmed Inc stock. As of the latest transaction made, Vanguard Group Inc holds 14,509,235 shares of INSM stock, worth $972 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,509,235

Previous 14,125,521 2.72%

Holding current value

$972 Million

Previous $438 Million 10.08%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$25.72 - $29.94 $9.87 Million - $11.5 Million	383,714 Added 2.72%	14,509,235 $394 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $5.15 Million - $6.98 Million	-219,991 Reduced 1.53%	14,125,521 $438 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $20.4 Million - $27.6 Million	1,024,956 Added 7.69%	14,345,512 $362 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $702,892 - $902,130	-42,755 Reduced 0.32%	13,320,556 $281 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $5.24 Million - $7.01 Million	322,480 Added 2.47%	13,363,311 $228 Million

Q4 2022 Feb 10, 2023	BUY	$16.98 - $23.15 $28.6 Million - $39.1 Million	1,686,861 Added 14.86%	13,040,831 $261 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $2.22 Million - $3 Million	106,326 Added 0.95%	11,353,970 $245 Million
Q2 2022 Aug 12, 2022	BUY	$17.07 - $25.71 $2.54 Million - $3.83 Million	148,938 Added 1.34%	11,247,644 $222 Million
Q1 2022 May 13, 2022	SELL	$20.42 - $28.13 $443,604 - $611,096	-21,724 Reduced 0.2%	11,098,706 $261 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $7.44 Million - $9.61 Million	287,229 Added 2.65%	11,120,430 $303 Million
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $4.19 Million - $5.5 Million	186,495 Added 1.75%	10,833,201 $298 Million
Q2 2021 Aug 13, 2021	BUY	$24.17 - $36.01 $257 Million - $383 Million	10,646,706 New	10,646,706 $303 Million

Others Institutions Holding INSM

# of Institutions

339

Shares Held

141M

Call Options Held

2.25M

Put Options Held

3.11M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.08B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Insmed Inc Transaction History